Gene Query: TUBA3D

Dataset Description Geneva Score
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [HCT RNA-Seq] 66.15
Paxillin regulates genomic networks in prostate cancer [C4-2] 53.53
RNA-sequencing of pediatric idiopathic dilated cardiomyopathy patients and healthy controls 38.98
Dtx3L and Androgen Signaling in Prostate Cancer 36.64
Universal alternative splicing of noncoding exons 35.82
Neonatal and adult human testis defined at the single-cell level 31.77
Novel mutations segregating with Complete Androgen Insensitivity Syndrome and their molecular characteristics. 30.41
RNA-Seq of cKIT+ sorted cells from 16-16.5 week old fetal testes and ovaries and RNA-Seq of TRA-1-60+ H1 hESCs 26.96
RNA-seq of tumor cells following angiopellosis extravasation 23.03
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 19.95
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 19.95
The Human Testis Cell Atlas via Single-cell RNA-seq 19.18
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 14.97
The conserved transcriptional landscapes in human spermatogenesis 13.61
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 12.38
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition 11.36
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy 10.57
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy [RNA-Seq] 10.57
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 10.04
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 7.64
Forkhead domain mutations in FOXA1 drive prostate cancer cell progression 7.25
RNA-seq in LNCaP cell line overexpressing WT or mutant FOXA1 7.25
Gene expression profile in response to HIF-1α inhibition together with PPARα activation and the postnatal factors (T3, IGF-1 and dexamethasone) in hiPSC-CMs 6.9
Functional Screening in Human Cardiac Organoids Reveals a Metabolic Mechanism for Cardiomyocyte Maturation 6.78
Genome wide transcript and miRNAanalysis of invitro and in-vivo generated human cardiac samples 6.3
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 5.33
BioProject PRJNA381064: Convergent origination of a Drosophila-like dosage compensation mechanism in a reptile lineage (Gene expression profiling in several tetrapod species, bulk tissue RNA-seq) 5.11
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 4.82
Characterization of sperm lncRNA and its differently expression in the sperm of asthenozoospermic patients 4.51
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 4.05
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 4.05
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [DNA Methylation] 3.72
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [RNA-Seq] 3.72
FMR1 reactivating treatments in Fragile X iPSC-derived neural progenitors in-vitro and in-vivo 3.55
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 3.43
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 3.43
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 3.28
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 3.24
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 3.2
Identification of HOXB13 target genes responsive to BET inhibitors 3.15
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 3.13
eRNA: A graphic user interface-based tool for RNA sequencing data analysis 2.8
eRNA: A graphic user interface-based tool for RNA sequencing data analysis [mRNA-Seq] 2.8
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 2.73
HNRNPL and its RNA Targets in Prostate Cancer 2.73
Analysis of human, chimpanzee, macaque and mouse tissue transcriptomes using Next Generation Sequencing 2.56
Role for citron kinase in prostate cancer growth 2.52
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 2.39
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 2.35
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation 2.15
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] 2.15
Genome-wide maps of H3K36me3 in ccRCC and RNA-seq of matched nephrectomy samples 2.12
RNA sequencing of matched nephrectomy samples [RNA-seq] 2.12
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 2.04
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] 1.99
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations 1.99
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 1.97
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] 1.84
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 1.83
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 1.8
Molecular analysis of renal cell carcinoma with unclassfied histology 1.8
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells (2) 1.43
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells 1.43
RNAseq analysis of ESRP regulated splicing events in prostate cancer 1.35
cKIT+ sorted cells from 57-137 day old fetal testes and ovaries 1.33
RNA-Seq of cKIT+ sorted cells from 53-137 day old fetal testes and ovaries and RNA-Seq of TRA-1-81+ H1 and UCLA1 hESCs. 1.33
Transcriptome profiling of Normal and Cancerous Prostate Cells 1.24
Differential gene expressions in the heart of hypertrophic cardiomyopathy patients 1.12
FOXA1 Chromatin Binding is Regulated by LSD1-Mediated Demethylation 1.12
RNA-Seq with DHT induction and/or GSK treatment at 24, 48 hrs and 2 weeks 1.12
Inhibition of ERG Activity in Patient Derived Prostate Cancer Xenografts using the Small Molecule Inhibitor YK-4-279 1.11
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 1.05
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 1.02
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 0.99
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 0.99
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 0.95
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 0.93
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 0.91
Transcriptomics profiles of patient-matched normal kidney and ccRCC pairs 0.84
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 0.84
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 0.79
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 0.79
Reconstruction of the Human Blood-Brain Barrier in vitro reveals a Pathogenic Mechanism of APOE4 in Pericytes 0.68
A genomic study of the contribution of DNA methylation to regulatory evolution in primates 0.67
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 0.63
An siRNA screen identifies CHD4 as a target for epigenetic therapy 0.62
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 0.59
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 0.57
In vitro modeling of human germ cell development using pluripotent stem cells 0.56
RNA-seq of naive and primed ES cells 0.55
Identification of miRNA-mRNA regulatory network for Human Atrial Aging 0.53
Identification of miRNA-mRNA regulatory network for Human Atrial Aging [mRNA] 0.53
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 0.5
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 0.5
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone 0.48
Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq 0.48
LNCaP treated with iBET 0.43
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 0.43
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 0.41
Molecular Criteria for Defining the Naive Human Pluripotent State 0.4
Dilated cardiomyopathy vs Myocarditis 0.38
Global Transcriptional analysis of human spinal cord and neocortical neuroepithelial stem (NES) cells 0.35
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 0.33
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 0.33
A prostate cancer chromatin interaction map 0.33
Effect of PBK knockdown on C4-2 cell transcriptome 0.29
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 0.28
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.25
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 0.25
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 0.25
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 0.23
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 0.23
Transcriptomic responses to Ivacaftor and prediction of Ivacaftor clinical responsiveness 0.23
Expression profiling of lncRNAs, miRNAs and mRNAs and their differential expression in leiomyoma using next generation RNA sequencing 0.23
Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors 0.23
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 0.21
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 0.21
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 0.21
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 0.21
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 0.2
The Human Testis Cell Atlas via Single-cell RNA-seq (Healthy men scRNA-seq data set) 0.2
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 0.2
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 0.19
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 0.19
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 0.18
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 0.17
Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma [RNA-Seq; normal samples] 0.17
RNA-Sequencing shows novel transcriptomic signatures in failing and non-failing human heart 0.17
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 0.16
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 0.16
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 0.16
Transcriptome analysis of human cumulus cells reveals hypoxia as the main determinant of follicular senescence. 0.16
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 0.16
NR2F2 study 0.16
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 0.15
miR941 overexpression experiment 0.14
Transcriptional profiling of healthy, eutopic and ectopic endometrial organoids 0.14
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 0.14
Paxillin regulates genomic networks in prostate cancer [LNCaP] 0.14
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 0.13
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 0.13
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 0.13
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 0.13
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 0.13
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 0.13
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 0.13
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 0.12
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (BGI12 RNA-Seq) 0.12
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 0.11
Integrative Genomic and Transcriptomic Analysis Identified Candidate Genes Implicated in the Pathogenesis of Hepatosplenic T-cell Lymphoma 0.11
Hepatosplenic T cell lymphoma 0.11
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 0.11
AMPK signaling for naïve pluripotency 0.11
AMPK signaling for naïve pluripotency [Hs] 0.11
Expression profiling of MCF-7 cells with treatment of TCDD 0.11
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 0.11
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 0.11
A radiolabeling-free, qPCR-based method for locus-specific pseudouridine detection 0.11
4sUDRB-seq: measuring transcription elongation and initiation genomewide 0.11
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 0.11
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 0.11
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 0.1
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 0.1
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 0.1
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 0.1
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 0.1
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 0.09
Profiling gene expression changes in primary ovarian tumors compared to matched normal fallopian tubes 0.09
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 0.09
G9a-Mediated Methylation of ERα Links the PHF20/MOF Histone Acetyltransferase Complex to Hormonal Gene Expression 0.09
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 0.09
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (nuclear RNA) 0.09
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 0.09
RNA-Seq with and without RNase treatment in PCa cell lines 0.08
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 0.08
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 0.08
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 0.08
RNA-seq in endometrial stromal tumors 0.08
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 0.08
Effect of circPTPRM on the biological behaviors of hepatocellular carcinoma cells in vitro and its clinical significance. 0.08
Functional Haploid Human Oocytes Generated from Polar Body Genomes (RNA-Seq) 0.08
Functional Haploid Human Oocytes Generated from Polar Body Genomes 0.08
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 0.08
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 0.07
Silencing SPIB in attached and floating state of H1703 lung cancer cells 0.07
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 0.07
The effect of engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 0.07
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 0.07
Expression data from miR340 overexpressing human A549 cells 0.07
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 0.07
Tracing Enhancer Networks using Epigenetic Traits (TENET) 0.07
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 0.07
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 0.07
Knockdown of FOXP1 promotes the development of lung adenocarcinoma 0.07
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 0.07
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 0.07
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells 0.07
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 0.06
Antiviral innate immunity of hepatitis C virus-infected stem cell-derived hepatocytes 0.06
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 0.06
AR-independent prostate cancer is sustained through FGF signaling 0.06
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 0.06
Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function 0.06
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 0.06
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 0.06
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 0.06
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches 0.06
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches [RNA-Seq] 0.06
The Wnt/β-catenin-signaling pathway is modulated by androgen ablation therapy for advanced clinical prostate cancer and contributes to androgen independent cell growth 0.06
Illumina HiSeq Sequencing on Breast cancer PDX samples 0.06
Lysine benzoylation is a novel histone mark 0.06
Lysine benzoylation is a novel histone mark [RNA-seq] 0.06
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit 0.06
ENCODE Cold Spring Harbor Labs Long RNA-seq 0.06
Expression profiles of cultured human epididymis cells reveal the functional diversity of caput, corpus and cauda regions. 0.06
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 0.05
Analysis of the Clustered Protocadherin (cPcdh) Locus in Human Pluripotent Stem and Derived Cells [RNA-seq II our of II] 0.05
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 0.05
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 0.05
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 0.05
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes [RNA-Seq] 0.05
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes 0.05
Genome-wide mapping of TEL-AML1 targets in acute leukemia 0.05
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 0.05
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 0.05
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 0.05
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 0.05
Gene expression in GBM with Cav3.2 inhibition 0.05
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 0.05
Interphase condensins regulate ligand-depedent enhancer activation 0.05
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 0.04
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 0.04
Analysis of gene expression in SKOV3 ovarian cancer cells after knockdown of the long non-coding RNA DNM3OS 0.04
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 0.04
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 0.04
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 0.04
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 0.04
Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network 0.04
Indoxyl sulfate stimulates angiogenesis by regulating reactive oxygen species production via CYP1B1 0.04
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 0.04
Effect of CHKA knockdown on C4-2 cell transcriptome 0.04
The pause-initiation limit restricts transcription activation in human cells 0.04
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 0.04
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 0.04
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreas cancer 0.04
Studying the selectivity of a small molecule Synucleozid on transcriptome 0.04
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 0.04
IRF2 is a master regulator of human keratinocyte stem cell fate 0.04
IRF2 is a master regulator of human keratinocyte stem cell fate [RNA-seq] 0.04
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 0.04
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 0.04
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 0.04
0.04
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 0.03
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 0.03
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 0.03
Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancer 0.03
Gene expression for surgically treated pancreatic cancer after one neoadjuvant vaccine dose 0.03
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 0.03
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 0.03
mRNA expression levels in splenic human mononuclear cells of mock- and HIV-1-infected humanized mice 0.03
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.03
The effect of spontaneous acquisition of an extra chromosome 7 for engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 0.03
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 0.03
HEK293 Heat-shock experiment 0.03
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 0.03
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 0.03
Transcriptome analysis of human airway epithelium infected by Human Bocavirus 1 0.03
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 0.03
RNA polymerase in pre-B-ALL cell lines 0.03
Repurposing of promoters and enhancers during mammalian evolution 0.03
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 0.03
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 0.03
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 0.03
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 0.03
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 0.03
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 0.03
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 0.03
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 0.03
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 0.03
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 0.03
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 0.03
Transcriptome of U251 cells overexpression complement component 7 0.03
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 0.03
RNA-sequencing of bulk CD19+ Thymic B cells from young (3 month - 4 year) and old (42 - 61 years) humans 0.03
RNA-sequencing of bulk CD19+ Thymic B cells from mice and humans 0.03
Small RNA-seq of human granulosa cells reveals miRNAs in FSHR and aromatase genes 0.03
High-throughput RNA sequencing of human preovulatory cumulus and mural granulosa cells (mRNA) 0.03
Determination of tRNA aminoacylation levels by high throughput sequencing 0.03
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 0.03
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 0.03
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 0.03
Human ES Cell-derived Hepatoblasts are an Optimal Lineage Stage for HCV Infection 0.03
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis 0.03
Leucegene: ALL sequencing 0.03
Defective transcription elongation in a subset of cancers confers immunotherapy resistance 0.03
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 0.03
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 0.03
Transcriptome analysis-identified long noncoding RNA CRNDE in maintaining endothelial cell proliferation, migration, and tube formation 0.02
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells 0.02
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 0.02
APT1 regulates the asymmetric partitioning of Notch and Wnt signaling during cell division 0.02
Lipid degradation promotes prostate cancer cell survival 0.02
Next generation sequencing identifies discrete classes of box C/D snoRNAs featuring different ends and RNA binding protein dependency 0.02
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 0.02
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 0.02
Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease 0.02
RNASeq of 4SU labelled nascent RNA in MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 0.02
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 0.02
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 0.02
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 0.02
FOXD3 is a novel tumor suppressor in lung cancer 0.02
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 0.02
Distinct epigenomes in CD4+ T cells of newborns, middle-ages and centenarians. 0.02
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 0.02
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 0.02
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 0.02
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 0.02
The role of m6A/m-RNA methylation in stress response regulation 0.02
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 0.02
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 0.02
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 0.02
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 0.02
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 0.02
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 0.02
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA 0.02
Identification of global XBP1s target gene expression in human prostate cancer cells 0.02
Next Generation Sequencing Quantitative Analysis of Wild Type and AML1-ETO Related Fusion Circular RNA (F-CircAE) Knockdown Kasumi-1 Cells Transcriptomes 0.02
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 0.02
The transcriptome and chromatin accessbility landscape of mammalian germline 0.02
RNA-seq of MLLT3-overexpressing cultued HSPC, compared to non-overexpressing and uncutured FL-HSPC [RNAseq_MLLT3_OE] 0.02
Mllt3 Governs Self-Renewal And Engraftment Of Human Hematopoietic Stem Cells 0.02
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 0.02
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 0.02
Priming mobilization of hair follicle stem cells triggers permanent loss of regeneration after alkylating chemotherapy 0.02
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 0.02
Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing 0.02
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 0.02
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 0.02
Differentially Expressed Genes for Atrial Fibrillation Identified using RNA Sequencing from Paired Human Left and Right Atrial Appendages. 0.02
RNA-sequencing analysis of CD4 T cells following ipilimumab therapy 0.02
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 0.02
Quantitative Analysis of PPARD Transcriptomes in Colon Cancer Cells by Next Generation Sequencing (NGS) 0.02
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 0.02
The MEF2B Regulatory Network 0.02
The MEF2B Regulatory Network - RNA-seq data 0.02
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 0.02
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 0.02
Comparing effects of perfusion and hydrostatic pressure on human chondrocytes using gene profiles 0.02
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 0.02
A transcriptome-wide divergence in protein translation scales with LIN28B expression 0.02
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 0.02
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 0.02
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 0.02
Measure transcript integrity using RNA-seq data 0.02
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 0.02
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 0.02
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 0.02
PTHrP overexpression in MCF7 cells 0.02
Mesothelioma xenografts in nude mice: PBS treated versus pirfenidone treated 0.02
Functional significance of the HIV-1 Tat signature amino acid residues 0.02
Identification of a LIF-responsive replication-competent human β cell 0.02
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans 0.01
Illumina Total RNA-seq in HeLa 0.01
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 0.01
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 0.01
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 0.01
Myc activation coordinates gene transcription and protein translation responses 0.01
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 0.01
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 0.01
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 0.01
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 0.01
Induced pluripotent stem cell modeling of bone marrow failure and MDS identifies therapeutic targets 0.01
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 0.01
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 0.01
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 0.01
Genes regulated by soluble guanylyl cyclase in VCaP prostate cancer cells 0.01
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 0.01
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 0.01
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 0.01
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 0.01
RNA sequencing (RNA-SEQ) of Human endothelial cells (HUVEC) in LFS, sFRP2OE, and WT conditioned media 0.01
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 0.01
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 0.01
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 0.01
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 0.01
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 0.01
Recovery and analysis of nascent RNA 0.01
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 0.01
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 0.01
UV_24h_GRO-Seq 0.01
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 0.01
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 0.01
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 0.01
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 0.01
Transcriptomic profiles of nonpregnant and term pregnant human myometrial tissues 0.01
Nonpregnant and term pregnant human myometrial tissues 0.01
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 0.01
Next generation sequencing of advanced non-castrate prostate cancer treated with docetaxel chemotherapy 0.01
RNA-seq data of small cell carcinoma of the bladder (SCCB) /urothelial carcinoma (Non-SCCB) clinical samples, and bladder-PARCB cell lines 0.01
Oncogenic roles of ARID5B in T-ALL 0.01
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 0.01
T47D xenografts treated with various combinations of ER- and PR-targeting therapies 0.01
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 0.01
Differentiation enhances Zika virus infection in neuronal brain cells 0.01
Oncogenic MYC induces a dependency on the spliceosome in human cancer 0.01
Exploring ILF2 regulatory genes by next-generation sequencing 0.01
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 0.01
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 0.01
BCL11B 0.01
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 0.01
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 0.01
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 0.01
Transcriptome analysis of VCaP xenografts resistant to dual therapy with abiraterone and enzalutamide 0.01
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 0.01
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 0.01
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 0.01
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.01
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 0.01
RNAseq of Breast cancer PDX samples 0.01
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 0.01
RNA-sequencing in irradiated and normal A549 cells. 0.01
Global gene expression profile of human peripheral blood-derived endothelial colony-forming cells is similar to coronary artery and umbilical vein endothelial cells 0.01
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 0.01
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 0.01
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 0.01
The transcriptome of Kawasaki Disease arteritis 0.01
CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops 0.01
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 0.01
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 0.01
Identification of miRNA signatures during the differentiation of hESCs into retinal pigment epithelial cells 0.01
PT2385 HIF2A inhibitor treatment of patient derived orthotopic xenograft neuroblastoma cells in the presence or absence of hypoxia 0.01
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 0.01
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 0.01
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 0.01
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 0.01
HNRNPM-regulated splicing dependencies in prostate cancer 0.01
Global transcriptome analysis of HAP1 cells 0.01
TOP2B disturbed the quality of human oocytes with advanced maternal age 0.01
REPROGRAMMING IDENTIFIES FUNCTIONALLY DISTINCT STAGES OF CLONAL EVOLUTION IN MYELODYSPLASTIC SYNDROMES 0.01
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 0.01
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 0.01
Transcriptome analysis revealed impaired cAMP responsiveness in PHF21A-deficient human cells 0.01
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia (RNA-Seq) 0.01
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia 0.01
Retinoic acid suppresses MYB in adenoid cystic carcinoma 0.01
Retinoic acid suppresses MYB in adenoid cystic carcinoma [RNA-seq] 0.01
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 0.01
Differentiation of human embryonic stem cells to HOXA+ hemogenic vasculature that resembles the aorta-gonad-mesonephros 0.01
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 0.01
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 0.01
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 0.01
Androgen Receptor-regulated genes in prostate cancer cells 0.01
RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells 0.01
Functional characterization of human T cell hyporesponsiveness induced by CTLA4-Ig 0.01
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 0.01
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 0.01
Genetic regulation of human adipose microRNA expression and its consequences for metabolic traits 0.01
Epigenome regulation during epidermal lineage commitment [RNA-seq] 0.01
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 0.0
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 0.0
Genome-wide analysis of Dengue virus 2 infected cells 0.0
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 0.0
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 0.0
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 0.0
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 0.0
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 0.0
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 0.0
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 0.0
Epigenomic plasticity enables human pancreatic alpha to beta cell reprogramming 0.0
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) 0.0
RNA sequencing of prostate cancers reveal insights on the prognostic significance of visibility on multi-parametric MRI 0.0
Enhancer divergence and cis-regulatory evolution in the human and chimpanzee neural crest 0.0
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 0.0
Improved post thaw function and genetic changes for mesenchymal stromal cells cryopreserved using multicomponent osmolyte solutions 0.0
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 0.0
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer 0.0
Profiling in vivo Bone Lesion (IVBL) and Orthotopic tumors by Next Generation Sequencing 0.0
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.0
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 0.0
Epigenome-wide analysis of DNA methylation in lung tissue shows concordance with blood studies and identifies tobacco smoke-inducible enhancers 0.0
Investigate A2M treatment on human prostate cancer and mouse liver 0.0
Investigate A2M treatment on human prostate cancer xenograft in mice 0.0
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 0.0
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 0.0
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 0.0
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 0.0
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 0.0
Human ovarian granulosa cell transcriptome 0.0
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 0.0
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 0.0
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 0.0
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 0.0
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 0.0
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 0.0
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 0.0
Comprehensive analysis of microRNA expression in regionalized human neural progenitor cells reveals microRNA-10 as a caudalizing factor 0.0
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells 0.0
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 0.0
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation